Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · IEX Real-Time Price · USD
37.65
-0.27 (-0.71%)
At close: Mar 28, 2024, 4:00 PM
37.30
-0.35 (-0.93%)
After-hours: Mar 28, 2024, 7:41 PM EDT
Janux Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Janux Therapeutics stock have an average target of 56.17, with a low estimate of 24 and a high estimate of 100. The average target predicts an increase of 49.19% from the current stock price of 37.65.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for JANX stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 3 |
Buy | 2 | 2 | 2 | 2 | 2 | 3 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 3 | 3 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
BTIG | BTIG | Strong Buy Initiates $62 | Strong Buy | Initiates | $62 | +64.67% | Mar 21, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $100 | Buy | Initiates | $100 | +165.60% | Mar 20, 2024 |
B of A Securities | B of A Securities | Strong Buy Maintains $24 → $48 | Strong Buy | Maintains | $24 → $48 | +27.49% | Mar 13, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $35 → $50 | Strong Buy | Maintains | $35 → $50 | +32.80% | Mar 11, 2024 |
Wedbush | Wedbush | Buy Maintains $24 → $53 | Buy | Maintains | $24 → $53 | +40.77% | Feb 27, 2024 |
Financial Forecast
Revenue This Year
2.77M
from 8.08M
Decreased by -65.71%
Revenue Next Year
1.70M
from 2.77M
Decreased by -38.67%
EPS This Year
-1.71
from -1.32
EPS Next Year
-1.97
from -1.71
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 5.3M | 5.3M | 5.3M | 26.3M | 294.0M |
Avg | 2.8M | 1.7M | 1.3M | 16.8M | 173.7M |
Low | n/a | n/a | n/a | n/a | 77.6M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -35.0% | 89.4% | 208.8% | 1,958.8% | 1,646.4% |
Avg | -65.7% | -38.7% | -25.0% | 1,220.4% | 931.7% |
Low | - | - | - | - | 360.8% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.38 | -1.58 | -1.88 | -2.27 | -1.63 |
Avg | -1.71 | -1.97 | -1.84 | -2.40 | -1.58 |
Low | -1.87 | -2.14 | -1.77 | -2.49 | -1.52 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.